Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ALLHAT Results Contradict Other Hypertension Trials – Study Investigators

Executive Summary

Two former ALLHAT investigators are speaking out against the trial's conclusion that diuretics are more effective than newer antihypertensive therapies

You may also be interested in...



NIH Has Room For Improvement In Releasing Study Data – WHI Director

The National Institutes of Health can improve its methods for releasing study data, Women's Health Initiative Director Barbara Alving, MD, said

NIH Has Room For Improvement In Releasing Study Data – WHI Director

The National Institutes of Health can improve its methods for releasing study data, Women's Health Initiative Director Barbara Alving, MD, said

Pfizer Asks Supreme Court To Protect “Right Of Reply” In Cases Like ALLHAT

The ALLHAT study report illustrates why manufacturers need a clearly articulated "right of reply" under the First Amendment, Pfizer told the Supreme Court in an amicus curiae brief filed in support of Nike's appeal of Kasky v. Nike

Related Content

UsernamePublicRestriction

Register

PS041457

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel